$KLRS SEC Filings

Filed On	Filing
26 Oct 2026	SCHEDULE 13G
28 Aug 2026	Form 4: Vandekop Amy O'Leary, VP, Corporate Controller Granted 10,000 Stock Option (Right to Buy)
11 Aug 2026	10-Q
11 Aug 2026	8-K: Results of Operations and Financial Condition
03 Aug 2026	Form 4: Keating Laurie, Director Granted 18,000 Stock Option (Right to Buy)
03 Aug 2026	Form 3: Keating Laurie, Director No securities owned
27 Jul 2026	Form 3: Vandekop Amy O'Leary, See Remarks Holds 948 shares of Common Stock
20 Jul 2026	Form 4: Bayko Liisa Ann, Chief Financial Officer Granted 220,000 Stock Option (Right to Buy)
20 Jul 2026	Form 3: Bayko Liisa Ann, Chief Financial Officer No securities owned
20 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation
17 Jul 2026	8-K: Regulation FD Disclosure; Other Events
06 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation
04 Jun 2026	Form 4: Jovan-Embiricos Morana, Director Granted 9,000 Stock Option (Right to Buy)
04 Jun 2026	Form 4: Ferrara Napoleone, Director Granted 9,000 Stock Option (Right to Buy)
04 Jun 2026	Form 4: Hallal David, Director Granted 9,000 Stock Option (Right to Buy)
04 Jun 2026	Form 4: Akkaraju Srinivas, Director Granted 9,000 Stock Option (Right to Buy)
04 Jun 2026	Form 4: Dybbs Michael, Director Granted 9,000 Stock Option (Right to Buy)
04 Jun 2026	Form 4: Adamis Anthony P, Director Granted 9,000 Stock Option (Right to Buy)
04 Jun 2026	Form 4: Patterson Leone D, Director Granted 9,000 Stock Option (Right to Buy)
04 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders

Comments